Eton Pharmaceuticals, Inc. ( ETON) - Stock Earnings
ETON Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
ETON Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 1.5 million USD | 21.3 million USD |
| 2026Q1 | 1.6 million USD | 24.3 million USD |
| 2026Q2 | 11.6 million USD | 37.6 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ETON Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -936000 USD | 31.6 million USD |
| 2024 | -3.8 million USD | 39.0 million USD |
| 2025 | -4.6 million USD | 80.0 million USD |
| 2026 Est. | — | — |
ETON
Price: $51.33
Earnings Per Share: 0.39 USD
P/E Ratio: 157.64
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 36257
Market Capitalization: 1.5 billion